ClinicalTrials.gg
Sign In

Retinal Vein Occlusion clinical trials

The registry lists 289 studies for Retinal Vein Occlusion across more than 10 countries. 32 are recruiting or about to start. 156 of them are mainly about Retinal Vein Occlusion (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Retinal Vein Occlusion studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
171
Status unknown
47
Terminated
24
Recruiting
18
Not yet recruiting
12
Active, not recruiting
10

Phase

Phase 3
58
Phase 2
56
Phase 4
40
Phase 1
34
Early Phase 1
4

Where

United States
106
China
36
France
30
Germany
26
United Kingdom
22
Canada
22

Who runs them

Novartis Pharmaceuticals (19) · Allergan (16) · Bayer (9) · National Eye Institute (NEI) (7) · Shahid Beheshti University of Medical Sciences (5) · Hoffmann-La Roche (4) · Clearside Biomedical, Inc. (4) · Assiut University (4)

What is being tested here

Drugs under test in Retinal Vein Occlusion studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Faricimab133
Chloroprocaine102
Apraclonidine101
Oxygen101
Remigromig101
Mecobalamin101
Ranibizumab01446
Aflibercept0418
Dexamethasone0414
Bevacizumab0713

Drug classes tested here Angiogenesis inhibitors 1 open · Local anesthetics 1 open · Corticosteroids 28

Coming up

4phase 3 studies under way
11studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 18 Retinal Vein Occlusion studies recruiting now, 13 (72%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (22%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
101 (6%)1 (6%)
1815 (83%)15 (83%)
3016 (89%)16 (89%)
4016 (89%)16 (89%)
5018 (100%)18 (100%)
6518 (100%)18 (100%)
7518 (100%)18 (100%)
8516 (89%)16 (89%)

Across all 289 studies, recruiting or not: 3% stop at 75 or younger and 1% at 65; 10% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Retinal Vein Occlusion studies take

Of 19 phase 4 interventional studies under Retinal Vein Occlusion, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 222 mo14–29 · 14 studies——
Phase 326 mo17–41 · 18 studies——
Phase 435 mo19–47 · 19 studies——
Interventional, no phase37 mo11–… · 22 studies——
Observational52 mo18–69 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 289. Browse all 289 → or search them.